Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
General Oncology
AddedFeb 15, 2024
UpdatedJun 18, 2026
General Oncology

General Oncology

Massachusetts-based General Oncology develops treatments for metastatic cancers, currently conducting a clinical trial for BRCA-related pancreatic cancer.

HQ
Burlington, MA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded in Burlington, Massachusetts, General Oncology is a pharmaceutical company dedicated to developing treatments for metastatic cancers. Their core mission is to cure metastatic cancer through innovative drug development and clinical trials. The company’s pipeline includes both clinical and preclinical studies targeting a variety of solid tumors and blood cancers. Currently, they are conducting a clinical trial (Clinical Trial GO-1) for an investigational treatment for BRCA-related metastatic pancreatic cancer, utilizing a combination of chemotherapy and stem cell support.

General Oncology has attracted notable attention in the medical community, enrolling multiple patients in their groundbreaking clinical trials. Their work has garnered interest from key investors and stakeholders in the healthcare sector. The company’s significant achievement includes the advancement of their investigational treatment to the clinical trial phase, demonstrating potential in treating BRCA-related metastatic pancreatic cancer. Through their focused efforts, General Oncology aims to make a substantial impact on cancer treatment and patient outcomes.

General Oncology - Similar Companies

G1 Therapeutics logo

G1 Therapeutics

g1therapeutics.com

Oncology Honduras logo

Oncology Honduras

D2G Oncology logo

D2G Oncology

d2g-oncology.com

Champions Oncology logo

Champions Oncology

Cullinan Oncology logo

Cullinan Oncology

Oncternal Therapeutics logo

Oncternal Therapeutics

oncternal.com

Clovis Oncology logo

Clovis Oncology

OncoTartis logo

OncoTartis

Oncolix logo

Oncolix

OncoPrecision logo

OncoPrecision

oncoprecision.bio

GenomOncology logo

GenomOncology

genomoncology.com

OncoSpherix logo

OncoSpherix

oncospherix.com

GO Therapeutics logo

GO Therapeutics

gotherapeutics.com

Western Oncolytics logo

Western Oncolytics

Curelab Oncology logo

Curelab Oncology

General Oncology - Quick Facts

Who are General Oncology's competitors?

Companies similar to General Oncology include G1 Therapeutics, Oncology Honduras, D2G Oncology and Champions Oncology.

When was General Oncology founded?

General Oncology was founded in 2015.

Where is General Oncology's headquarters located?

General Oncology's headquarters is located in Burlington, MA, US.

When was General Oncology's last funding round?

General Oncology's most recent funding round was for $6M (USD) in June 2019.

How much has General Oncology raised to-date?

As of Jun 25, 2019, General Oncology has raised a total of $6M (USD).

How many employees does General Oncology have?

General Oncology has 7 employees as of Feb 5, 2024.

General Oncology - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatments
Tags
  • Biotech
  • Healthtech
  • Pharmaceutical
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 7 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621400Outpatient Care Centers
  • 621490Other Outpatient Care Centers
  • 621491HMO Medical Centers
  • 623000Nursing and Residential Care Facilities
SIC
  • 8010Offices And Clinics Of Doctors Of Medicine
  • 8011Offices And Clinics Of Doctors Of Medicine